MENU
+Compare
SLDB
Stock ticker: NASDAQ
AS OF
Oct 14 closing price
Price
$6.23
Change
+$0.22 (+3.66%)
Capitalization
483.96M

SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis

Solid Biosciences Inc is a life science company... Show more

Industry: #Biotechnology
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SLDB with price predictions
Oct 08, 2025

Aroon Indicator for SLDB shows an upward move is likely

SLDB's Aroon Indicator triggered a bullish signal on October 08, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 159 similar instances where the Aroon Indicator showed a similar pattern. In of the 159 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SLDB's RSI Indicator exited the oversold zone, of 52 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 22, 2025. You may want to consider a long position or call options on SLDB as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SLDB just turned positive on September 23, 2025. Looking at past instances where SLDB's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

SLDB moved above its 50-day moving average on October 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SLDB crossed bullishly above the 50-day moving average on October 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SLDB advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where SLDB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLDB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SLDB broke above its upper Bollinger Band on September 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.874) is normal, around the industry mean (23.456). P/E Ratio (0.000) is within average values for comparable stocks, (54.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.164). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (347.799).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SLDB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of novel gene therapy platform for advancing disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
88
Web
https://www.solidbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYSGX55.460.88
+1.61%
Rydex S&P SmallCap 600 Pure Growth A
MIISX7.870.09
+1.16%
BNY Mellon Income Stock Inv
QISGX32.800.32
+0.99%
Federated Hermes MDT Small Cap Growth IS
ASCLX13.73N/A
N/A
AB Select US Long/Short C
GEQZX65.81-0.08
-0.12%
GuideStone Funds Equity Index Investor

SLDB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
+0.84%
EDIT - SLDB
46%
Loosely correlated
-4.30%
BEAM - SLDB
45%
Loosely correlated
-3.53%
ALLO - SLDB
45%
Loosely correlated
+3.25%
DYN - SLDB
44%
Loosely correlated
-0.14%
SYRE - SLDB
44%
Loosely correlated
-1.18%
More